Registration Now Open – FPP2020!

Registration for The Future of Pediatric Practice 2020 is now open!

Returning to Disney’s Yacht & Beach Club Resorts and adding extra educational content over the 3 day event, you will not want to miss FPP2020!

Load up on extra continuing education credits by attending a NEW Mental Health Symposium for primary care providers, followed by a Pediatric Dermatology Workshop – What Pediatricians Need to Know on Children’s Skin Disorders Friday afternoon before enjoying the friendly yet fierce competition of the Brain Bowl. Join your family Friday night for food, dancing, and photo opportunities with Disney characters at the Family Reception!

Learn from top pediatric experts on Saturday in one of the two tracks – one designed for providers in primary care and the other designed for providers in the hospital setting, before joining your family in the afternoon to enjoy the amenities of Disney’s Yacht & Beach Club Resorts, Disney’s Boardwalk, the Food & Wine Festival at Epcot, or any of the other easily accessible Disney parks!

Sunday morning will offer plenary sessions with big names in pediatrics, followed by a bonus track for anyone interested in starting or running a successful private pediatric practice.

Special room rates at Disney’s Yacht & Beach Club Resorts and specially priced tickets to Disney’s theme parks make it easy for attendees to enjoy the evenings and add an extra day for relaxation with family and friends. Register today and see what has made The Future of Pediatric Practice the Florida conference to attend each year!

Visit the event website to see the full schedule, speaker line-up, and venue details.

When
Friday, September 4, 2020 – Sunday, September 6, 2020

Where
Disney’s Yacht & Beach Club Resorts
1800 Epcot Resorts Boulevard
Lake Buena Vista, Florida 32830-8443

 

Happy Holidays from FCAAP!

With the holiday season upon us, FCAAP Offices will be closed Tuesday, December 24 through Sunday, December 29 and Tuesday, December 30 through Wednesday, January 1 for the holidays. We will respond to email and voicemail messages when we return, and appreciate your patience and continued support.

On behalf of FCAAP, we wish you all healthy, safe, and Happy Holidays and a Happy New Year!

Young Physicians Leadership Alliance Faculty Applications—Due January 31

The American Academy of Pediatrics’ (AAP) Section on Early Career Physicians (SOECP) is pleased to welcome faculty applications for the 2020-2022 class of the Young Physicians Leadership Alliance (YPLA). Applicants must be an active member of the AAP for the full duration of the program. The YPLA is funded through the AAP Insurance Program and Kabrita USA. 
Contact: AAP’s Kim Vandenbrook in Membership Engagement and Marketing

Florida Healthy Kids MCO Change Update

Changes are coming to the Florida Healthy Kids (FHK) program next year.

Starting January 1, 2020, three Managed Care Organizations (MCOs) will provide coverage for all Florida Healthy Kids members—Aetna Better Health of Florida (Aetna) and Simply Healthcare (Simply) will provide statewide coverage, and Community Care Plan will also be available in the following 8 counties: Indian River, Okeechobee, St. Lucie, Martin, Palm Beach, Broward, Miami-Dade and Monroe.  
 
Therefore, after December 31, 2019, Staywell Kids, United Healthcare and Sunshine Health will no longer provide coverage for Florida Healthy Kids members.  
 
Impacted families were asked to select a new 2020 MCO during a Special Open Choice Period (October 28-November 30) so new member ID cards can be mailed and available for services starting January 1. If you are interested in becoming an Aetna, Simply, or Community Care Plan provider, please click here for Provider Relations contacts. 
 
IMPORTANT 
Florida Healthy Kids is one of four Florida KidCare partners. Florida KidCare is the combined Medicaid and Children’s Health Insurance Program (CHIP) program, offering a seamless continuum of coverage for children from birth through the end of age 18. 
 
These changes apply only to Florida Healthy Kids members (children ages 5-18). If you are a network provider for other Florida KidCare programs, nothing else will change. 
 
There are no changes to the following Florida KidCare programs: 
Children’s Medical Services Managed Care Plan (CMS Plan) for children with special medical needs: (birth-18) 
Medicaid for Children: (birth-18) 
MediKids: (children ages 1-4) 

Download the Provider Bulletin for complete details including the FHK TRANSITION OF CARE POLICY and FLORIDA HEALTHY KIDS 2020 MCO MAP.

Ate too much at Thanksgiving? Lose the “wait” and save 8%!

With a beautiful venue and exciting new CME topics, FCAAP’s Annual Conference is going to be bigger and better than ever in 2020! We know you’re excited to attend, so we want to help you lose the “wait” this holiday weekend. For a limited time, take 8% off registration rates for FCAAP’s Annual Conference: The Future of Pediatric Practice 2020!

Labor Day Weekend – September 4-6, 2020

Why attend The Future of Pediatric Practice 2020?

•             Hosted at Disney’s Yacht & Beach Club Resorts

•             Network with fellow Florida providers and FCAAP Leaders

•             Earn CME, CEU, and MOC 2 credits while learning from top pediatric experts

•             Cheer on Florida’s top pediatric residency programs during the Brain Bowl

•             Enjoy food, fun, dancing, and meet Disney characters at the Family Reception

•             Special hotel rates and discounted tickets to Disney theme parks, valid for the Epcot International Food & Wine Festival

Discounted rates start at 12:00am EST on Friday, Nov. 29 and run through 11:59pm EST on Monday, Dec. 2.

Click here to download the registration form. 

Send completed forms to aadams@fcaap.org by the deadline to reserve your spot at the discounted rate!

Download the flyer to share with your colleagues.

 

Zika 201 – Free Educational Conference!

As pediatricians in South Florida continue to care for children with confirmed cases of Congenital Zika Syndrome and those who were exposed to the Zika virus in utero, additional education is needed regarding the known effects of the Zika virus on infants and children as well as the recommended screenings to be performed as the child develops.  

To effectively expand upon the work completed through this project over the past couple years, FCAAP will host a FREE one‐day accredited educational conference for pediatric healthcare providers. Sessions will be led by South Florida area experts with experience caring for Zika exposed and infected children. Topics will include:

Serology, PCR Testing, and Interpretation – Dr. Samita Andreansky
How to Screen for Zika‐Related Audiological Defects – Dr. Robert Fifer
How to Screen for Zika‐Related Neurodevelopmental Defects – Dr. Roberto Lopez-Alberola
Local Radiological Research Findings Related to Zika‐Infected Children – Dr. Gaurav Saigal
Local Nephrological Research Findings Related to Zika‐Infected Children – Dr. Chryso Katsoufis
Local Cardiological Research Findings Related to Zika‐Infected Children – Dr. Juanita Hunter
End Organ Damage Correlation to Zika Exposure – Dr. Ivan Gonzalez

CME, CEU, and MOC Part 2 credits will be available.

Registration is now open. See the full conference agenda here. For more information, please contact Cheval Breggins at cbreggins@fcaap.org.

Limited Partner Packages are available! View the Partner Prospectus, visit the event website, or contact Alicia Adams at aadams@fcaap.org for more information.

 

2019 Florida Medicaid Enhanced Fee Schedule

FCAAP’s Medicaid Access Committee has persuaded Florida Medicaid to publish the Enhanced Medicaid Fee Schedule (i.e, the Medicare Equivalent Rates) on the AHCA website and to keep the fee schedule regularly updated. This will allow physicians eligible for the enhanced payment rate for seeing Medicaid children to know exactly what the various Medicaid MMAs should be paying them.

The Enhanced Fee Schedule can be found on the AHCA website.
Scroll down to “MPIP Rates for Children’s Primary Care Codes.” Since the rates on the AHCA website only show those codes not listed on the Medicare Site (that is, those that must be calculated), you can see all the codes here.

Mosquito Borne Illnesses

A message from Andrea Morrison, Vector-Borne Disease Surveillance Coordinator, Florida Department of Health, Division of Disease Control and Health Protection, Bureau of Epidemiology:

As we continue to see increased dengue virus activity in the Americas, now is the time for providers to consider dengue. This is also the time of year most at-risk for introduction into Florida. Both PCR and antibody testing is available commercially and PCR testing is the only way to definitively diagnose acute dengue infections. Patients who have been previously exposed to another dengue serotype may show elevated IgG titers and have transient or no elevated dengue IgM titers, making identification of such cases difficult without PCR testing on the acute sample. It will be important to also follow up on possible cases with positive dengue IgG results to determine if an acute infection consistent with dengue fever was reported. Additionally, patients with suspected dengue fever also should be evaluated, tested, and managed for possible Zika or chikungunya virus infection if travel was to areas where these viruses are present, as co-infection is possible.

Refer to the following information sheets for more information.

Chikungunya

Dengue

Zika

E-cigarette Users Having Seizures

FDA Continues to Receive Reports of E-cigarette Users Having Seizures, More Information Needed to Determine Possible Causes

Since initially alerting the public on April 3 to reports of some e-cigarette users experiencing seizures, FDA has since received 118 new reports of similar incidents. In total, including those posted in April, the agency has received 127 reports of neurological events following e-cigarette use that occurred between 2010 and 2019. This does not necessarily indicate an increase in frequency or prevalence of such incidents. 

At this time, FDA has not been able to identify any specific brand of tobacco product, or identifiable product problem, associated with these incidents. However, the agency remains concerned about the possibility of an association between e-cigarette use and seizures or other similar medical conditions and encourages the public, including e-cigarette users and medical professionals, to provide as much information as possible when reporting health or safety problems stemming from tobacco products through the online Safety Reporting Portal (SRP).

Healthcare providers in particular are reminded to ask patients about e-cigarette (or “vape” use), particularly when providing care following a neurological event. Healthcare providers are also encouraged to help patients to report any adverse experiences from tobacco use through the Safety Reporting Portal, such as referring patients to the website, making relevant medical records available, or submitting a report on a patient’s behalf. FDA has posted the full reports [PDF – 23MB], redacted in accordance with applicable laws, as a reference for those reporting seizures or other neurological symptoms following e-cigarette use. 

Details about adverse experiences are important in helping FDA to identify concerning trends and clear patterns or causes for particular incidents. When reporting an adverse experience, please be sure to include as much information as possible about:

  • The affected person (whether a user or nonuser)
  • The name of the manufacturer
  • The brand name, model, and serial number of the device or e-liquid, if applicable
  • Where the device or e-liquid was purchased
  • If the device or e-liquid was modified in any way or if the device malfunctioned
  • Any use or exposure to other tobacco products, medications, supplements, substances of abuse or toxins around the same time
  • Any other symptoms or warning before the adverse experience, such as nausea, vomiting, change in the user’s behavior, alertness, vision or hearing
  • Details about the pattern of product use or exposure before the adverse experience (duration, amount and intensity of e-cigarette use) as well as the time between the latest use and the adverse experience
  • Details about health effects, including specific areas of the body affected, how symptoms progressed, how long they lasted, the course of the recovery, and the medical testing or care and decisions rendered
  • If you had testing for levels of nicotine, cotinine or other byproduct in your blood or urine, include results and the time between the last product use and the body fluid collection
  • Underlying health conditions and health history, especially any history of seizures earlier in life and any blood relatives with a history of seizures
  • Whether product use continued or not after the event and whether additional events occurred
  • Whether you reported the event elsewhere, such as to a poison control center, the retailer, or the manufacturer

Safety Reporting Portal users can upload relevant medical records, photos, or other files that include or supplement this information. Providing follow-up information weeks, months, or years later that are linked to the initial report and give final outcomes can also be useful.

Learn More Here.

Hepatitis A Public Health Emergency

Health Care Provider Information
Hepatitis A Public Health Emergency
August 2019

Florida, like other parts of the United States, is experiencing a serious hepatitis A virus (HAV) outbreak. Since 2018, there have been more than 22,000 cases of HAV in the United States. In Florida, there have been more than 2500 cases since 2019 and more than 2,000 cases since January 2019. This outbreak has come at a personal cost to our residents, as 78% of individuals with HAV have been hospitalized and 31 individuals have died. In response, on August 1, 2019, with the support of Governor Ron DeSantis and Lieutenant Governor Jeanette Nuñez, Florida’s State Surgeon General declared a Public Health Emergency.

The key to controlling this outbreak is vaccinating individuals at highest risk for contracting HAV, which includes persons who use intravenous or non-intravenous drugs and the homeless population. In addition, individuals who are at risk for serious outcomes need to be vaccinated. The HAV vaccines are inactivated viruses and have an excellent safety profile. Two doses separated by six months are recommended; however, one dose is 93% effective. Information about HAV from the CDC is available HERE. Information specific to the Department of Health’s response and vaccination sites can be found HERE.

As a health care provider, please consider the following:

  1. If you are caring for individuals in the inpatient, outpatient, or emergency setting with intravenous or non-intravenous illicit drug use, who are homeless, or who are currently incarcerated, vaccinate them.
  2. If an individual is treated in an emergency room or other acute care setting after being administered an opioid antagonist, such as naloxone, vaccinate them prior to discharge
  3. Identify your patients with underlying liver disease and offer the HAV vaccine. If such individuals are hospitalized, consider vaccinating them prior to discharge.
  4. Individuals over 60-years-of-age with complex medical conditions, such as diabetes mellitus and cardiovascular disease, are at risk for serious complications or even death if they contract HAV. If you are in a critically impacted county as defined in the declaration, identify patients with serious medical conditions and offer the HAV vaccine. If such individuals are hospitalized, consider vaccinating them before discharge.
  5. Vaccinate men who have sex with men.
  6. Vaccinate individuals who work with persons with a history of drug abuse or homelessness in a non-health care setting.
  7. Hepatitis may present with non-specific flu-like and/or gastrointestinal symptoms. Health care providers are encouraged to screen for hepatitis A in patients with such symptoms by ordering liver function tests and transaminase levels (ALT/SGPT, AST/SGOT), in addition to hepatitis A serology. These tests should also be considered for individuals who present with jaundice, light-colored stools, or dark-colored urine.
  8. As always, use standard precautions when interacting with patients. Handwashing with soap and water by health care providers after contact with HAV-positive patients or high-risk populations is essential. Commonly used alcohol-based hand sanitizing products are NOT effective against HAV.
  9. All surfaces in restrooms and bathing areas should be disinfected at least once per day at your facilities. A standard ready-to-use 1 to 10 bleach solution applied to a surface for one minute is effective in destroying the virus on surfaces.
  10. Notify your county health department immediately when HAV infection is confirmed in your patients.
  11. Please contact the Department of Health at HepA@FLHealth.gov with questions and concerns.

Thank you for your commitment to public health in Florida.